Gamma
Payments companies reported to CMS as associated with Gamma. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gamma, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gamma
These are the largest totals companies reported as associated with Gamma. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Haddad | Glenview, IL | Orthopaedic Surgery | $235,080.64 |
| Timothy Achor | Houston, TX | Orthopaedic Trauma | $144,106.37 |
| Sanjit Konda | New York, NY | Orthopaedic Surgery | $115,210.67 |
| Marcus Sciadini | Baltimore, MD | Orthopaedic Trauma | $103,692.86 |
| David Forsh | New York, NY | Orthopaedic Surgery | $100,683.65 |
| Michael Maceroli | Atlanta, GA | Orthopaedic Trauma | $99,799.55 |
| Robert Wetzel | Cleveland, OH | Orthopaedic Trauma | $95,138.71 |
| Conor Kleweno | Seattle, WA | Orthopaedic Trauma | $89,333.16 |
| Stuart Gold | Torrance, CA | Orthopaedic Surgery | $86,001.96 |
| Justin Haller | Salt Lake City, UT | Orthopaedic Trauma | $80,331.65 |
Prescribed Gamma?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.